About
Dr. Puja K. Mehta, MD, FACC, FAHA, is an Associate Professor in the Division of Cardiology at Emory University and the Director of Women’s Translational Cardiovascular Research at the Emory Women’s Heart Center (EWHC). She is Board-certified in Cardiology and is a Fellow of the American College of Cardiology and the American Heart Association. She attended undergraduate school at Georgia Institute of Technology and earned her medical degree from the Medical College of Georgia. She completed internal medicine residency and a four-year cardiovascular fellowship at Emory University. Dr. Mehta completed an additional year of specialized fellowship training in Women’s Heart Disease at Cedars-Sinai’s Barbra Streisand Women’s Heart Center. Dr. Mehta’s clinical interest are management of angina and risk factors, and heart disease prevention, focusing on behavioral approaches such as exercise, nutrition, and stress reduction. Her research is NIH-funded and focuses on microvascular dysfunction, biomarkers, and the role of mental stress in heart disease in women. She has presented her work at national cardiology meetings and has published over 130 manuscripts in journals such as the Journal of American College of Cardiology, European Heart Journal, Circulation, and the American Journal of Physiology. In addition to clinical care and research, she enjoys teaching medical students, residents, and fellows in the Emory School of Medicine. Puja K. Mehta, MD FACC is a preventive cardiologist with specialized training in women’s heart disease. She is Director of the Non-invasive Vascular Function Research Laboratory and Co-Director of the Cardio-Oncology Program in the Barbra Streisand Women's Heart Center at the Cedars-Sinai Heart Institute. Dr. Mehta trained in Internal Medicine and Cardiology at Emory University, and then completed a specialized research fellowship in Women’s Health and Heart Disease at Cedars-Sinai. Her clinical interest is treatment of persistent chest pain, microvascular coronary dysfunction, heart disease prevention and behavioral approaches such as exercise, nutrition, and stress reduction for heart disease. Dr. Mehta's research is NIH-funded and includes the role of mental stress in heart disease, exploring the brain-heart connection and novel approaches to treating chest pain in women.
View More >>Skills
Experience
Publication
-
December, 2022
Ischemia and no obstructive coronary arteries (INOCA): A narrative review
Myocardial ischemia with no obstructive coronary arteries (INOCA) is a chronic coronary syndrome condition that is increasingly being recognized as a substantial contributor to adverse cardi...
-
May, 2021
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor ...
Aims To provide multi-national, multi-ethnic data on the clinical characteristics and prognosis of patients with microvascular angina (MVA). Methods and results The Coronary Vasomotor D...
-
November, 2020
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructi...
Background: Myocardial infarction with nonobstructive coronary arteries (MINOCA) occurs in 6% to 15% of myocardial infarctions (MIs) and disproportionately affects women. Scientific stateme...
-
November, 2019
Gender in cardiovascular medicine: chest pain and coronary artery disease
Ischaemic heart disease (IHD) remains the leading cause of morbidity and mortality among women and men yet women are more often underdiagnosed, have a delay in diagnosis, and/or receive subo...
-
February, 2019
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women
Background: Currently as many as one-half of women with suspected myocardial ischemia have no obstructive coronary artery disease (CAD), and abnormal coronary reactivity (CR) is commonly fo...
-
September, 2017
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association
Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions t...
-
September, 2017
Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol
Background Recent data from the National Cardiovascular Data Registry indicate that women with ST-segment-elevation myocardial infarction (STEMI) continue to have higher mortality and repor...
-
July, 2017
Quality and Equitable Health Care Gaps for Women: Attributions to Sex Differences in Cardiovascular Medicine
The present review synthesizes evidence and discusses issues related to health care quality and equity for women, including minority population subgroups. The principle of “sameness” or ...
-
May, 2017
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women�...
Background Women with signs and symptoms of ischemia, no obstructive coronary artery disease (CAD) and preserved left ventricular ejection fraction (EF) often have diastolic dysfunction and...
-
March, 2016
Preeclampsia and Vascular Function: A Window to Future Cardiovascular Disease Risk
Preeclampsia affects ∼3%–7% of all pregnancies and is the third leading cause of maternal mortality globally. Growing evidence indicates that preeclampsia results from vascular dysfuncti...
Scholar9 Profile ID
S9-012025-1808549

Publication
(23)

Article Reviewed
(0)

Citations
(2065)

Network
(21)

Conferences/Seminar
(0)